Companies Directory

Immunetrics takes a Quantitative Systems Pharmacology (QSP) approach to creating mechanistic mathematical models of biological systems, accelerating development of drugs, clinical diagnostics, and medical/commercial devices. We predict FDA-approved endpoints through in silico clinical trial simulations of acute or chronic inflammatory diseases. We deliver proprietary mathematical models encompassing biological pathways and interactions that span levels of detail from intracellular signaling pathways, cell-cell interactions, and organ systems. We also utilize complex analyses to help better understand your data and create novel hypotheses. Our robust bio-simulation platform represents 10+ years of work by our team of experts. Our capabilities allow our clients to bring their health care solutions to market more quickly, at a lower cost, and with decreased risk. Immunetrics was founded in 2001 and collaborates regularly with the most significant names in drug development, medical devices, and academia. Our team includes a cross disciplinary group of experts in physiology, molecular biology, immunology, computational biology, machine learning, and software engineering in a highly collaborative environment. We provide the expertise and experience to build functional models to inform our clients in their decision making process. Immunetrics'​ offices and computing center are conveniently located in South Side of Pittsburgh, PA. Our city is the home of the University of Pittsburgh Medical Center, with its world-class Critical Care Medicine, Surgery and Immunology departments; Carnegie Mellon University, with its world-renowned Engineering and Mathematics groups; and the Pittsburgh Supercomputing Center.

Immuni T is specialized in services for biotherapeutics and immunomodulators at very competitive rates, in particular in customized cell-based assays, flow cytometry analysis and GLP/GCLP bioanalysis. We have developed an ex vivo method for assessing the immunogenic potential of new biotherapeutics and biosimilars, an assay performed in freshly-collected PBMC from a number of donors. This assay, for example, could assist you in the selection of the less immunogenic lead from a set of variants or to compare the immunogenic profile of a biosimilar to that of its originator. It is a rapid and cost-effective means for the evaluation of the immunogenic potential of a molecule in a human system. We perform the development and validation of immunogenicity methods and of ligand-binding assays for PK analysis for pre-clinical and clinical programs. We developed functional customized cell-based assays such as cytotoxicity assays (e.g. ADCC, CDC, in PBMC, sub-cell compartments or whole blood) and other assays such as Treg or NK functional assays. Overall, Immuni T performs cell-based assays, human ex-vivo immunogenicity prediction/comparison assays for new biotherapeutics as well as immunogenicity tests for biotherapeutics in clinical development; ligand-binding assays for the quantification/detection of peptides, proteins or nucleic acids; immuno assays based on flow cytometry analysis for determination of cell function and molecules quantification; multiplex analysis on Luminex as well as customization, development and validation of assays for pre-clinical and clinical sample analysis in a GLP-compliant environment.

IMMUNIS delivers world class Intellectual property (IP) and patent services globally. IMMUNIS is a pioneer in offering Patent services. IMMUNIS provides top-quality, cost effective, customer friendly Patent Search & Analytics, Patent illustrations/Drawings, Drafting & filing, Prosecution and Trademark services across the globe. We specialise in gathering, managing and using IP information to provide you with the services and solutions that matter the most for your business. We take the complexity out of your Intellectual Property Management, so that you concentrate and enrich your business We handle all of your patent needs, doesn’t matter whether they are Computer, Software, Hardware, IT, Electrical & Electronic, Mechanical, Automobile, Medical, Chemistry, DNA sequence or biotech. At Immunis, we understand the true dynamic nature of your business; we continuously refine our processes and set higher standards to provide you with better quality of service. What we offer: Patent Filing and Drafting National Phase Filing (India) PCT Filing Utility and Design Drawings Novelty searches State-of-the-art searches Validity searches Infringement / FTO searches Patent Illustrations/Drawings Trademarks Our Advantage: See why so many companies are turning to 'Immunis'​ for their IP Management Solutions. » Dedicated staff for each client » Timely deliverables » Expert multi-faceted talent pool » Experience » Proven skills » Accurate analysis and reports » Registered patent agents » Cost savings and much more! IMMUNIS Info SERVICES PVT LTD. www.immunisip.com www.immunisdrawings.com Phone No: +1 678 916 6366 Email Id: info@immunisip.com info@immunisdrawings.com

Immunize.org (formerly Immunization Action Coalition) established its website (www.immunize.org) in 1994. It is a nonprofit organization that works to increase vaccination rates and prevent disease through advocacy and education. Immunize.org creates and distributes educational materials for healthcare professionals and the public that enhance the delivery of safe and effective vaccination services. Immunize.org advocates for policies that remove barriers to access to vaccinations for people of all ages and facilitates communication about the safety, efficacy, and use of vaccines within the broad immunization community of patients, parents, healthcare organizations, and government health agencies. For more than three decades, the Centers for Disease Control and Prevention (CDC) has worked in concert with and provided financial support to Immunize.org for the purpose of educating healthcare professionals about U.S. vaccine recommendations. IZ Express is the free weekly e-newsletter produced by Immunize.org with over 54,000 subscribers. IZ Express keeps you informed about important vaccine updates from CDC and FDA. You’ll read about newly posted Vaccine Information Statements and their translations, and new education materials from Immunize.org, CDC, AAP, and other trusted partners. It also features online and in-person educational opportunities, many offering free continuing education credit. To subscribe, simply provide your name and email address at www.immunize.org/subscribe. We will never share your contact information. Disclaimer: www.immunize.org/iacadmin/disclaimer.asp

Immuno Diagnostic is a Distributor of Diagnostic and Research reagents and instruments in Finland and surrounding countries. We represent leading suppliers in the fields of molecular diagnostics, histopathology, imaging as well as life science research reagents and food diagnostics. Being present in the Nordic markets since 1983, we can provide our customers with a range of high quality products and excellent customer and technical service. We represent well established suppliers providing our customers a reliable source for research tools with modern technologies. Our quality management system is ISO9001:2015 certified. Immuno Diagnostic Oy is a part of AddLife AB.

Immuno is a federally licensed medical laboratory. Immuno provides products and services to physicians with a focus on helping physicians by providing real relief for their patients with chronic unsolved conditions. 88% of consumers rate themselves from "good"​ to "excellent"​ in their health, yet 56% have been diagnosed with a one or more chronic conditions. If there was one food that was causing your chronic condition; your headaches; your stomach pains; your skin issues; would you want to know what that food is? That is what we do at Immuno, we precisely pinpoint the foods that are toxic to your body and guide you to better health.

ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular has concluded a phase 2 trial of its lead product candidate, ICT-107, a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells. ImmunoCellular’s pipeline also includes: ICT-121, a dendritic cell immunotherapy targeting the CD133 antigen on stem cells in recurrent glioblastoma; ICT-140, a dendritic cell immunotherapy targeting antigens on ovarian cancer stem cells; and the Stem-to-T-cell research program which engineers the patient’s hematopoietic stem cells to generate antigen-specific cancer-killing T-cells.

Saving Critical Time and Resources Today, to Bring New Medicine to Patients Tomorrow! - Protocol Design - Lab Guidance - Data Analysis - Site Monitoring - Tech Transfer

Immunordic increases accessibility of unique nanobodies for targeted therapeutics, diagnostics and research tools. Our platform is based on the largest and most cost-efficient synthetic nanobody library on the market thus allowing Immunordic to reduce prices and turnaround time compared to competing options on the market.